Sandra Pennell Biography and Net Worth

SVP of Delcath Systems

Sandra has 20+ plus years in a variety of financial areas including complete oversight of the Finance and Accounting function specializing in SEC reporting, equity raises, FP&A, all accounting functions in addition to treasury experience related to debt financings and internal investment decisions. She previously held the position of VP, Finance at Invivyd, Inc. and prior to that she was the VP & Corporate Controller, Principal Accounting Officer at Vericel Corporation. Sandra earned a Bachelor and Master of Science in Accountancy from University of Illinois at Urbana-Champaign – College of Business.

What is Sandra Pennell's net worth?: The estimated net worth of Sandra Pennell is at least $300.60 thousand as of November 17th, 2023. Pennell owns 30,000 shares of Delcath Systems stock worth more than $300,600 as of December 5th. This net worth estimate does not reflect any other investments that Pennell may own. Learn More about Sandra Pennell's net worth.
How old is Sandra Pennell?: Pennell is currently 44 years old. There are 4 older executives and no younger executives at Delcath Systems. The oldest executive at Delcath Systems is Mr. Gerard J. Michel MBA, MS, CEO & Director, who is 61 years old. Learn More on Sandra Pennell's age.
How do I contact Sandra Pennell?: The corporate mailing address for Pennell and other Delcath Systems executives is 1633 BROADWAY SUITE 22C, NEW YORK NY, 10019. Delcath Systems can also be reached via phone at 212-489-2100 and via email at [email protected]. Learn More on Sandra Pennell's contact information.
Has Sandra Pennell been buying or selling shares of Delcath Systems?: Sandra Pennell has not been actively trading shares of Delcath Systems over the course of the past ninety days. Most recently, on Friday, November 17th, Sandra Pennell bought 30,000 shares of Delcath Systems stock. The stock was acquired at an average cost of $2.43 per share, with a total value of $72,900.00. Following the completion of the transaction, the senior vice president now directly owns 30,000 shares of the company's stock, valued at $72,900. Learn More on Sandra Pennell's trading history.
Who are Delcath Systems' active insiders?: Delcath Systems' insider roster includes Gil Aharon (Director), Gerard Michel (CEO), Sandra Pennell (SVP), John Purpura (COO), Steven Salamon (Director), John Sylvester (Director), and Vojo Vukovic (Chief Medical Officer). Learn More on Delcath Systems' active insiders.
Are insiders buying or selling shares of Delcath Systems?: During the last twelve months, Delcath Systems insiders bought shares 1 times. They purchased a total of 11,500 shares worth more than $98,095.00. The most recent insider tranaction occured on November, 11th when CEO Gerard J Michel bought 11,500 shares worth more than $98,095.00. Insiders at Delcath Systems own 17.4% of the company. Learn More about insider trades at Delcath Systems.
Information on this page was last updated on 11/11/2025.

Sandra Pennell Insider Trading History at Delcath Systems

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/17/2023	Buy	30,000	$2.43	$72,900.00	30,000

Sandra Pennell Buying and Selling Activity at Delcath Systems

Delcath Systems Company Overview

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Today's Range

Now: $10.02

$9.57

$10.12

50 Day Range

MA: $9.94

$8.19

$12.36

2 Week Range

Now: $10.02

$8.12

$18.23

Volume

605,955 shs

Average Volume

796,411 shs

Market Capitalization

$353.81 million

P/E Ratio

1,002.00

Dividend Yield

N/A

Beta

0.41

Sandra Pennell Biography and Net Worth

What is Sandra Pennell's net worth?

How old is Sandra Pennell?

How do I contact Sandra Pennell?

Has Sandra Pennell been buying or selling shares of Delcath Systems?

Who are Delcath Systems' active insiders?

Are insiders buying or selling shares of Delcath Systems?